Theseus Pharmaceuticals Inc (THRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2021 | 12-2020 | 09-2020 | 12-2019 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -4,473 | -11,997 | -9,107 | -7,183 |
| Depreciation Amortization | 1 | 2 | 2 | 2 |
| Accounts payable and accrued liabilities | -122 | N/A | N/A | N/A |
| Other Working Capital | -1,276 | 933 | 64 | -179 |
| Other Operating Activity | 670 | 6,210 | 5,427 | 2,553 |
| Operating Cash Flow | $-5,200 | $-4,852 | $-3,614 | $-4,807 |
| Cash Flows From Investing Activities | ||||
| Investing Cash Flow | $N/A | $0 | $N/A | $0 |
| Cash Flows From Financing Activities | ||||
| Other Financing Activity | 99,892 | 11,992 | 7,994 | 2,993 |
| Financing Cash Flow | $99,892 | $11,992 | $7,994 | $2,993 |
| Beginning Cash Position | 8,457 | 1,317 | 1,317 | 3,131 |
| End Cash Position | 103,149 | 8,457 | 5,697 | 1,317 |
| Net Cash Flow | $94,692 | $7,140 | $4,380 | $-1,814 |
| Free Cash Flow | ||||
| Operating Cash Flow | -5,200 | -4,852 | -3,614 | -4,807 |
| Free Cash Flow | -5,200 | -4,852 | -3,614 | -4,807 |